Introduction
Although there is considerable evidence that sphingomyelin is not only concentrated in the plasma membranes of eukaryotic cells but also oriented almost exclusively on the external surface [l-31, there has been some controversy about the actual site of synthesis of plasma membrane sphingomyelin. Originally it was thought to be made in situ in the plasma membrane, which represents the largest pool of sphingomyelin within most cells [4-61. Subsequently, evidence has been produced for synthesis of sphingomyelin in an internal pool (probably the early Golgi) and for its translocation to the cell surface by a vesicular route similar to that taken by membrane proteins [7-111. This evidence is based partly on the observation that inhibitors of vesicular transport block the appearance of sphingomyelin at the cell surface and partly on the results of liver cell fractionation, which suggest that sphingomyelin synthetic activity is concentrated in the early Golgi [8, 12, 131. The work described here demonstrates that although there is a site of sphingomyelin synthesis which is probably in the early Golgi, this is not the site which is responsible for the synthesis of plasma membrane sphingomyelin. The major site of plasma membrane sphingomyelin synthesis appears to be in the endosomal pathway involved in the recycling of plasma membrane.
Materials and methods
Baby hamster kidney (BHK) 21 cells were cultured in 3.5 cm dishes in Glasgow minimal essential medium (MEM) supplemented with 5% fetal calf serum, as described previously [14] . Cells were incubated in the presence of 20 pCi [3H]acetate (New England Nuclear) with or without addition of 0.3 p M monensin (Sigma Chemical Co., Poole, Dorset, U.K.). After 4 h, some samples were incubated for 20 min with Bacillus cereus sphingomyelinase (0.1 unit) to determine the amount of radioactive sphingomyelin which had reached the surface. All the samples were then extracted with 1.9 ml 2:l v/v methanoVchloroform. Lipids were It has been demonstrated previously that monensin prevents the delivery of sphingomyelin to the cell surface [19] , but our results show for the first time that there is a decrease in the net synthesis of surface sphingomyelin [20] (Figure 1) . A combination of monensin and external sphingomyelinase gives a decrease in sphingomyelin radioactivity which is no greater than their separate effects, showing that monensin is affecting mainly the sur-
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Volume 2 I 22, 231, which all cause a decrease in plasma membrane sphingomyelin, also promote the conversion of cholesterol to cholesterol ester. This can be seen as a generalized response to a decreased ratio of sphingomyelin to cholesterol in the cell surface and emphasizes the importance which is attached to the maintenance of a normal sphingomye1in:cholesterol ratio in the plasma membrane. Inhibition of sphingomyelin synthesis by monensin is associated with an accumulation of ceramide (together with some glucosylceramide) which exactly matches the decrease in synthesis of surface sphingomyelin (Figure 1) [20]. Since monensin is thought to block vesicular transport between the medial-and trans-Golgi [24] , this suggests that it is interfering with the vesicular transport of ceramide from the medial-Golgi to a more distal site where it can be converted into sphingomyelin. The accumulation of ceramide seems likely therefore to be in the medial-Golgi, where some of it is apparently available to be glucosylated to form glucosylceramide. As noted previously [25] , the addition of carbohydrate residues to glucosylceramide to form complex gangliosides is also blocked by monensin and HFA, probably because this processing of glycolipids occurs at sites distal to the medial-Golgi.
Synthesis of internal sphingomyelin in the early Golgi
Despite the above evidence for a site of plasma membrane sphingomyelin biosynthesis distal to the medial Golgi, our work indicates that some de novo synthesis of sphingomyelin does occur in the early Golgi, since about 50% of total new synthesis of sphingomyelin is unaffected by monensin ( Figure  1 ). This is an internal pool which does not reach the cell surface, where it can be degraded by external sphingomyelinase, and could correspond to the internal pool of sphingomyelin (accounting for about 30% of the total by mass) which we have identified previously in BHK cells [26] . The precise location of this pool is unknown, but, based on compositional data [27] and stereological information about the sizes of membrane compartments in BHK cells [28] , it appears that the only intracellular 6.5 -
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organelles that could accommodate this amount of sphingomyelin are endosomes or endoplasmic reticulum. The internal sphingomyelin seems unlikely to be in endosomes because it labels more rapidly with radioactive choline than does plasma membrane sphingomyelin [26] , whereas endosomes would be expected to label more slowly than plasma membrane. One possibility is that synthesis of the internal pool of sphingomyelin is associated with retrograde transport of vesicles from the Golgi to the endoplasmic reticulum, which is known to occur from experiments on protein translocation. This would fit in with the observation that BFA, which is thought to promote this retrograde transport [29] , greatly increases the size of the internal pool of sphingomyelin in BHK cells [ 151.
Resynthesis of sphingomyelin and its return to the cell surface after its degradation to ceramide by exogenous sphingom yelinase If, as suggested above, surface sphingomyelin is synthesized at a site distal to the medial Golgi, what is the precise location of this site in the cell? An indication that it could be endosomal has been obtained from experiments in which RI-IK cells have been treated with sphingomyelinase and allowed to resynthesize sphingomyelin after removal of the enzyme [14] . Complete synthesis and return of sphingomyelin to the surface occurs in about 3 h (Figure Z) , demonstrating a capacity for sphingomyelin synthesis which is at least five-fold larger than the normal synthesis of this lipid in growing cells. This resynthetic process not only has similar kinetics to plasma membrane endocytic recycling, but also is inhibited by conditions which block endocytic events (K.-J. Kallen, P. Quinn and D. Allan, unpublished results) . Thus energy depletion, N-ethylmaleimide, digitonin and AIF; , which inhibit endocytic events also block resynthesis of sphingomyelin (Figure 3) . In addition, mitotic cells, which have a reduced ability to endocytose, show little capacity to resynthesize cell-surface sphingomyelin (K.-J. Kallen, P. Quinn and D. Allan, unpublished results) .
In contrast to their effects on the de n o w synthesis of plasma membrane sphingomyelin, neither HFA nor monensin have any effect on the resynthesis or return to the surface of sphingomyelin which has been degraded to ceramide on the cell surface ( Figure 2 ). Since both monensin and BFA block vesicular transport through the Golgi cisternae, this important result suggests that ceramide generated in the cell surface does not need to pass through the Golgi apparatus in order to be converted into sphingomyelin. This conclusion is supported by the observation that very little of the ceramide is converted into glycolipids (K.-J. Kallen, P. Quinn and D. Allan, unpublished results) , the initial steps of whose synthesis occurs in the early Golgi [13, 301, indicating that ceramide at the cell surface cannot reach the early Golgi either by vesicular or nonvesicular routes. Thus it appears that the resynthesis of sphingomyelin and its return to the surface depends on a non-Golgi site of synthesis, which could be part of the endocytic plasma membrane recycling pathway.
An endosomal site for de novo synthesis of plasma membrane sphingom yelin?
Considering its large synthetic capacity, it is tempting to suggest that the site of sphingomyelin synthesis in the recycling pathway may also be responsible for normal biosynthesis of plasma membrane sphingomyelin, using ceramide which has made its way through the vesicular transport pathway in the Golgi apparatus. If synthesis occurs on the endocytic pathway, then there could be a direct route by which ceramide exiting from the Golgi could reach the endosomal pathway. However the bulk of exocytic membrane flow is directly to the plasma membrane, so most of the entrained ceramide is likely to reach the cell surface. The implication is that most ceramide reaches the endosoma1 site of sphingomyelin synthesis only after it has passed through the exocytic pathway to the plasma membrane and has undergone endocytosis. Such a tortuous route for transport of ceramide could be consistent with the relatively slow kinetics of plasma membrane sphingomyelin synthesis [26 1.
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